Medication use, renin–angiotensin system inhibitors, and acute care utilization after hospitalization in patients with chronic kidney disease
暂无分享,去创建一个
K. Tuttle | Joshua J. Neumiller | R. Alicic | S. McPherson | R. Short | C. Corbett | B. J. Gates | L. Gregg | K. Daratha | H. Miller
[1] M. Jose,et al. Medication-Related Factors and Hospital Readmission in Older Adults with Chronic Kidney Disease , 2019, Journal of clinical medicine.
[2] N. Pannu,et al. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury , 2018, JAMA internal medicine.
[3] K. S. Rocha,et al. Medication Regimen Complexity Measured by MRCI: A Systematic Review to Identify Health Outcomes , 2018, The Annals of pharmacotherapy.
[4] David M. White. Appropriate Use of Opioids in Patients with Kidney Diseases. , 2018, Clinical journal of the American Society of Nephrology : CJASN.
[5] Cynthia F Corbett,et al. Medication Therapy Management after Hospitalization in CKD: A Randomized Clinical Trial. , 2018, Clinical journal of the American Society of Nephrology : CJASN.
[6] Neil R. Powe,et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy , 2017, The Lancet.
[7] Michael L. Johnson,et al. Discharge medication complexity and 30‐day heart failure readmissions , 2016, Research in Social and Administrative Pharmacy.
[8] K. Tuttle,et al. Medication Intervention for Chronic Kidney Disease Patients Transitioning from Hospital to Home: Study Design and Baseline Characteristics , 2016, American Journal of Nephrology.
[9] K. Tuttle,et al. Association Between Prescription Opioid Use and Biomarkers of Kidney Disease in US Adults , 2016, Kidney and Blood Pressure Research.
[10] J. Fonda,et al. Medication Complexity, Medication Number, and Their Relationships to Medication Discrepancies , 2016, The Annals of pharmacotherapy.
[11] Maarten W. Taal,et al. The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study , 2015, BMC Nephrology.
[12] G. Peterson,et al. Retrospective evaluation of potentially inappropriate prescribing in hospitalized patients with renal impairment , 2015, Current medical research and opinion.
[13] Vittal R. Nagar,et al. Chronic Opioid Pain Management for Chronic Kidney Disease , 2015, Journal of pain & palliative care pharmacotherapy.
[14] Cynthia F Corbett,et al. Predicting Potential Postdischarge Adverse Drug Events and 30-Day Unplanned Hospital Readmissions From Medication Regimen Complexity , 2014, Journal of patient safety.
[15] K. Tuttle,et al. Association of Co-Occurring Serious Mental Illness with Emergency Hospitalization in People with Chronic Kidney Disease , 2014, American Journal of Nephrology.
[16] Christopher L. Greer,et al. Medication Regimen Complexity and Hospital Readmission for an Adverse Drug Event , 2014, The Annals of pharmacotherapy.
[17] Cynthia F Corbett,et al. Risks of subsequent hospitalization and death in patients with kidney disease. , 2012, Clinical journal of the American Society of Nephrology : CJASN.
[18] R. Al-Ramahi. Medication prescribing patterns among chronic kidney disease patients in a hospital in Malaysia. , 2012, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
[19] Y. Hassan,et al. Adverse drug events in hospitalized patients with chronic kidney disease. , 2010, International journal of clinical pharmacology and therapeutics.
[20] K. Alexander,et al. Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease: A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network R , 2010, Circulation.
[21] R. Wolfe,et al. Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] Charles E McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[23] Johnson George,et al. Development and Validation of the Medication Regimen Complexity Index , 2004, The Annals of pharmacotherapy.
[24] H. Manley,et al. Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[25] B. Ballermann,et al. Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. , 2001, Circulation.